Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study

2019

Background Tyrosine kinase inhibitor-induced hypothyroidism is associated with favorable survival in patients with various cancers.

Keywords:

References

Citations